US EditionAfter NIH staffing cuts, cancer patient in clinical trial worries she may lose crucial time
- Natalie Phelps, a 43-year-old mother of two with colorectal cancer, was accepted last month into an ongoing NIH clinical trial for T-cell receptor-based immunotherapy.
- Her treatment timeline grew uncertain after the Trump administration's late March HHS restructuring cut about 1,200 NIH staff, including some scientists on her trial.
- The restructuring centralized functions across NIH’s 27 institutes and centers, aiming to save $1.8 billion annually by reducing roughly 10,000 federal health employees.
- Phelps said the cell engineering process now takes eight weeks instead of four due to fewer researchers, and she worries that trial delays could threaten her life.
- These cuts and funding reductions came amid rising colorectal cancer rates in younger adults, challenging efforts to advance patient care through clinical trials.
Insights by Ground AI
Does this summary seem wrong?
27 Articles
27 Articles
All
Left
4
Center
9
Right
3
Prenatal Testing Incidentally Finds Cancer in Mothers, Becomes Focus of New National Institutes of Health Long-term Study
Discovery could lead to new clinical laboratory testing for cancer screening in new mothers Any clinical laboratory test that returns unexpected results is worth looking into more deeply. Such was the case with a recent study conducted by the National Institutes of Health (NIH), which investigated cases of pregnant women who received “unusual” results to […] The post Prenatal Testing Incidentally Finds Cancer in Mothers, Becomes Focus of New Nat…
Coverage Details
Total News Sources27
Leaning Left4Leaning Right3Center9Last UpdatedBias Distribution56% Center
Bias Distribution
- 56% of the sources are Center
56% Center
L 25%
C 56%
R 19%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
